• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 1
      Home Page: AACE Endocrinology and Diabetes - 5 hour(s) ago

      Metamorphosis: AACE Clinical Case Reports has been reimagined as AACE’s new open access journal, AACE Endocrinology and Diabetes (AED), publishing original research and reviews alongside case reports and video and visual vignettes. We are now accepting submissions in anticipation of our June 2025 launch! The journal welcomes clinical and translational research, epidemiologic studies, including prospective and retrospective observational studies, systematic and scoping reviews, case reports, visual and

      Source: www.endocrinologydiabetes.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	vtangpricha
        vtangpricha

        Feeling inspired at #AACE2025 ? Publish your work at AACE Endocrinology and Diabetes. Newly launched open access journal by @TheAACE https://t.co/8c8LVhmwKg

    • Mashup Score: 4
      Elect Officer & Member, National Board of Directors Positions | ADA - 5 hour(s) ago

      Explore officer and board of directors positions at the ADA. Join us in making a difference for millions of Americans with diabetes and their support networks.

      Source: diabetes.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	ADA_DiabetesPro
        ADA_DiabetesPro

        The @AmDiabetesAssn is seeking diverse leaders with vision & expertise! The National Board of Directors is accepting applications for its 2025 Class. Board members play a vital role in shaping our organization's future. Apply by July 31, 2024, 8:00 pm ET. https://t.co/9EOOiRgABZ https://t.co/KqO5fDKjj8

    • Mashup Score: 3
      Mexico's junk food and soda taxes - 8 hour(s) ago

      Mexico’s type 2 diabetes crisis, with a prevalence of 16·9%, has made the country a focal point for fiscal policies targeting non-communicable diseases (NCDs). Since 2014, Mexico’s sugar-sweetened beverage (SSB) and junk food taxes and front-of-package warning labels have garnered global attention, reinforced by a March 2025 ban on junk food in schools. These measures, driven by evidence linking ultra-processed foods and SSBs to obesity and type 2 diabetes, are expected to substantially reduce consumption, but pragmatic challenges remain.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Mexico's junk food and soda taxes https://t.co/yY8hSWaeam #obesity #PublicHealth #FREE to read with registration (also FREE)

    • Mashup Score: 0
      Women's Health | ADA - 8 hour(s) ago

      Women’s health is crucial to overall health care. Diabetes—whether gestational, type 1, or type 2—poses unique challenges for women at every life stage, making focused care essential.

      Source: professional.diabetes.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	ADA_DiabetesPro
        ADA_DiabetesPro

        Our Women’s Health Initiative, supported in part by @BlueCrossMN, @CVSHealth & @Dexcom, is advancing equitable gestational diabetes care. Explore tools for specialists—infographics, webinars & more ⬇️ https://t.co/lMv0DwTImb https://t.co/ukXgBauNkH

    • Mashup Score: 0
      Understanding How GLP-1 RAs Achieve Sustained Weight Loss - 9 hour(s) ago

      Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

      Source: www.endocrinologyadvisor.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	EndoAdvisor
        EndoAdvisor

        From @ClinicalAdvisor: Trials have confirmed the efficacy of #GLP1RAs in achieving clinically sustained #WeightLoss in people with #obesity without #diabetes. https://t.co/lP8J804L9U

    • Mashup Score: 0
      Thyroid Cancer-Associated Syndromes May Be More Prevalent Than Current Estimates - 9 hour(s) ago

      Thyroid cancer-associated syndromes, including multiple endocrine neoplasia type 2, were significantly more prevalent than current estimates.

      Source: www.endocrinologyadvisor.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	EndoAdvisor
        EndoAdvisor

        Although some #ThyroidCancer-associated syndromes were more prevalent than current estimates, most pathogenic variant carriers did not have thyroid cancer. @CUAnschutz @CUEndocrinology @LMFendo https://t.co/qPQYgGB2s5

    • Mashup Score: 0
      Speakers to stress importance of preparing for heart failure ‘tidal wave’ - ADA Meeting News - 10 hour(s) ago

      Adrian F. Hernandez, MD, MHS, and other experts will outline new developments in heart failure screening, prevention, and therapy related to diabetes.

      Source: www.adameetingnews.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	ADA_DiabetesPro
        ADA_DiabetesPro

        #ADASciSessions Preview: Experts will discuss the importance of preparing for heart failure ""tidal wave."" Find out more in ADA Meeting News: https://t.co/5bePCBGC8l https://t.co/cVFplZJAFH

    • Mashup Score: 0
      GLP-1 RA Outcomes Comparable Between Pediatric Patients, Adults With Obesity - 10 hour(s) ago

      GLP-1 RAs were associated with significant reductions in body weight, BMI, and waist circumference among pediatric patients with obesity.

      Source: www.endocrinologyadvisor.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	EndoAdvisor
        EndoAdvisor

        #GLP1RA use was associated with significant reductions in body weight, BMI, and waist circumference among #pediatric patients with #obesity. https://t.co/84B4auZ7fD

    • Mashup Score: 0
      Diabetes Prevention Alliance | ADA - 10 hour(s) ago

      Recommending patients to a CDC-recognized program for prevention of Type 2 diabetes

      Source: professional.diabetes.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	ADA_DiabetesPro
        ADA_DiabetesPro

        May is #NationalWomensHealthAwarenessMonth. This month, we're encouraging you to share the National Diabetes Prevention Program as a resource for those you care for living with prediabetes. Discover more at https://t.co/p4fCFepYE9. https://t.co/EjgCABQoDU

    • Mashup Score: 0
      Pharma Fridays - May 16, 2025 - Endocrine News - 11 hour(s) ago

      An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome On May 12, Amylyx Pharmaceuticals, Inc.  announced positive Week 48 data from the Phase 2 open-label HELIOS clinical trial of AMX0035 (sodium phenylbutyrate [PB] and…

      Source: endocrinenews.endocrine.org
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	Endocrine_News
        Endocrine_News

        Pharma Fridays - May 16, 2025 @AmylyxPharma reports new data on Wolfram syndrome treatment @US_FDA approved @Merck's endocrine cancer drug Menopause treatment on the horizon from @AbCelleraBio @AscendisPharma shares data on hypoparathyroidism treatment https://t.co/JgKTwFbvyk

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings